380 related articles for article (PubMed ID: 16059735)
1. Transport and cytotoxicity of paclitaxel, docetaxel, and novel taxanes in human breast cancer cells.
Ehrlichova M; Vaclavikova R; Ojima I; Pepe A; Kuznetsova LV; Chen J; Truksa J; Kovar J; Gut I
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):95-105. PubMed ID: 16059735
[TBL] [Abstract][Full Text] [Related]
2. Transport, metabolism, cytotoxicity and effects of novel taxanes on the cell cycle in MDA-MB-435 and NCI/ADR-RES cells.
Ehrlichová M; Ojima I; Chen J; Václavíková R; Němcová-Fürstová V; Vobořilová J; Simek P; Horský S; Souček P; Kovář J; Brabec M; Gut I
Naunyn Schmiedebergs Arch Pharmacol; 2012 Oct; 385(10):1035-48. PubMed ID: 22855252
[TBL] [Abstract][Full Text] [Related]
3. Cell death induced by taxanes in breast cancer cells: cytochrome C is released in resistant but not in sensitive cells.
Ehrlichová M; Koc M; Truksa J; Naldová Z; Václavíková R; Kovárr J
Anticancer Res; 2005; 25(6B):4215-24. PubMed ID: 16309219
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cell death-inducing effect of novel taxane SB-T-1216 and paclitaxel in breast cancer cells.
Kovár J; Ehrlichová M; Smejkalová B; Zanardi I; Ojima I; Gut I
Anticancer Res; 2009 Aug; 29(8):2951-60. PubMed ID: 19661300
[TBL] [Abstract][Full Text] [Related]
5. Cell death induced by novel fluorinated taxanes in drug-sensitive and drug-resistant cancer cells.
Vobořilová J; Němcová-Fürstová V; Neubauerová J; Ojima I; Zanardi I; Gut I; Kovář J
Invest New Drugs; 2011 Jun; 29(3):411-23. PubMed ID: 20013348
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel-2'-Ethylcarbonate prodrug can circumvent P-glycoprotein-mediated cellular efflux to increase drug cytotoxicity.
Tanino T; Nawa A; Kondo E; Kikkawa F; Daikoku T; Tsurumi T; Luo C; Nishiyama Y; Takayanagi Y; Nishimori K; Ichida S; Wada T; Miki Y; Iwaki M
Pharm Res; 2007 Mar; 24(3):555-65. PubMed ID: 17245652
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol augments paclitaxel treatment in MDA-MB-231 and paclitaxel-resistant MDA-MB-231 breast cancer cells.
Sprouse AA; Herbert BS
Anticancer Res; 2014 Oct; 34(10):5363-74. PubMed ID: 25275030
[TBL] [Abstract][Full Text] [Related]
8. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
[TBL] [Abstract][Full Text] [Related]
9. Antitumour activity of novel taxanes that act at the same time as cytotoxic agents and P-glycoprotein inhibitors.
Ferlini C; Distefano M; Pignatelli F; Lin S; Riva A; Bombardelli E; Mancuso S; Ojima I; Scambia G
Br J Cancer; 2000 Dec; 83(12):1762-8. PubMed ID: 11104578
[TBL] [Abstract][Full Text] [Related]
10. Alterations in tumor necrosis factor signaling pathways are associated with cytotoxicity and resistance to taxanes: a study in isogenic resistant tumor cells.
Sprowl JA; Reed K; Armstrong SR; Lanner C; Guo B; Kalatskaya I; Stein L; Hembruff SL; Tam A; Parissenti AM
Breast Cancer Res; 2012 Jan; 14(1):R2. PubMed ID: 22225778
[TBL] [Abstract][Full Text] [Related]
11. [Sensitivity to chemotherapeutic drugs of polyploid tumor cells induced by a spindle poison nocodazole].
Hao J; Yuan BB; Xu YF; Yu J; Liu GY; Wang DH
Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):419-24. PubMed ID: 22967442
[TBL] [Abstract][Full Text] [Related]
12. Modulation of paclitaxel transport by flavonoid derivatives in human breast cancer cells. Is there a correlation between binding affinity to NBD of P-gp and modulation of transport?
Václavíková R; Boumendjel A; Ehrlichová M; Kovár J; Gut I
Bioorg Med Chem; 2006 Jul; 14(13):4519-25. PubMed ID: 16516478
[TBL] [Abstract][Full Text] [Related]
13. MRP2 (ABCC2) transports taxanes and confers paclitaxel resistance and both processes are stimulated by probenecid.
Huisman MT; Chhatta AA; van Tellingen O; Beijnen JH; Schinkel AH
Int J Cancer; 2005 Sep; 116(5):824-9. PubMed ID: 15849751
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux.
Chavanpatil MD; Patil Y; Panyam J
Int J Pharm; 2006 Aug; 320(1-2):150-6. PubMed ID: 16713148
[TBL] [Abstract][Full Text] [Related]
15. Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.
Goble S; Bear HD
Surg Clin North Am; 2003 Aug; 83(4):943-71. PubMed ID: 12875604
[TBL] [Abstract][Full Text] [Related]
16. Systematic expression analysis of genes related to multidrug-resistance in isogenic docetaxel- and adriamycin-resistant breast cancer cell lines.
Li WJ; Zhong SL; Wu YJ; Xu WD; Xu JJ; Tang JH; Zhao JH
Mol Biol Rep; 2013 Nov; 40(11):6143-50. PubMed ID: 24078162
[TBL] [Abstract][Full Text] [Related]
17. Multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cells.
Wang H; Vo T; Hajar A; Li S; Chen X; Parissenti AM; Brindley DN; Wang Z
BMC Cancer; 2014 Jan; 14():37. PubMed ID: 24447372
[TBL] [Abstract][Full Text] [Related]
18. Syl611, a novel semisynthetic taxane derivative, reverses multidrug resistance by p-glycoprotein inhibition and facilitating inward transmembrane action.
Zhang Y; Li H; Wang H; Su F; Qu R; Yin D; Dai J; Li Y; Chen X
Cancer Chemother Pharmacol; 2010 Oct; 66(5):851-9. PubMed ID: 20052473
[TBL] [Abstract][Full Text] [Related]
19. Altered DNA methylation is associated with docetaxel resistance in human breast cancer cells.
Kastl L; Brown I; Schofield AC
Int J Oncol; 2010 May; 36(5):1235-41. PubMed ID: 20372798
[TBL] [Abstract][Full Text] [Related]
20. Effects of paclitaxel and docetaxel on EGFR-expressing human carcinoma cells under normoxic versus hypoxic conditions in vitro.
Skvortsova I; Skvortsov S; Haidenberger A; Devries A; Nevinny-Stickel M; Saurer M; Lukas P; Seppi T
J Chemother; 2004 Aug; 16(4):372-80. PubMed ID: 15332713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
